141 related articles for article (PubMed ID: 6435518)
1. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Thompson KD; O'Keefe JP; Tatarowicz WA
Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
[TBL] [Abstract][Full Text] [Related]
2. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
John JF; Twitty JA
Antimicrob Agents Chemother; 1984 Nov; 26(5):781-4. PubMed ID: 6440481
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
Baltch AL; Sutphen NT; Smith RP; Conley PE
Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
Smith BR; LeFrock JL; Donato JB; Joseph WS; Weber SJ
Antimicrob Agents Chemother; 1986 Feb; 29(2):355-8. PubMed ID: 3717937
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
6. Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.
Iravani A; Welty GS; Newton BR; Richard GA
Antimicrob Agents Chemother; 1985 Apr; 27(4):449-51. PubMed ID: 3890724
[TBL] [Abstract][Full Text] [Related]
7. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
[TBL] [Abstract][Full Text] [Related]
10. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
Anan N; Toba S; Ito A; Nakamura R; Tsuji M
Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Smith SM
Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of amifloxacin and two of its metabolites.
Venezia RA; Prymas LA; Shayegani A; Yocum DM
Antimicrob Agents Chemother; 1989 May; 33(5):762-6. PubMed ID: 2751287
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).
Cornett JB; Wagner RB; Dobson RA; Wentland MP; Bailey DM
Antimicrob Agents Chemother; 1985 Jan; 27(1):4-10. PubMed ID: 3885845
[TBL] [Abstract][Full Text] [Related]
15. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
Van der Auwera P; Schuyteneer F
J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.
Garcia I; Bodey GP; Fainstein V; Ho DH; LeBlanc B
Antimicrob Agents Chemother; 1984 Sep; 26(3):421-3. PubMed ID: 6508271
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.
Bassey CM; Baltch AL; Smith RP; Conley PE
Antimicrob Agents Chemother; 1984 Sep; 26(3):417-8. PubMed ID: 6439116
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
Chow AW; Wong J; Bartlett KH; Shafran SD; Stiver HG
Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
Sofianou DC; Douboyas JP
J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
[TBL] [Abstract][Full Text] [Related]
20. In-vitro susceptibility of clinical isolates of Pseudomonas aeruginosa to beta-lactam and aminoglycoside antibiotics.
Sofianou DC; Vrenas S; Doumboyas J
J Chemother; 1989 Dec; 1(6):391-3. PubMed ID: 2515260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]